Evidence map›Paper›PMID 25590277›Full record

ArticleToxins2015

The cytolytic activity of vaginolysin strictly depends on cholesterol and is potentiated by human CD59.

Milda Zilnyte, Česlovas Venclovas, Aurelija Zvirbliene, Milda Pleckaityte

Open access · goldAbstract read
In one paragraph

Article in Toxins, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Research Progress on the Correlation BetweenFrontiers in cellular and infection microbiology · 2022
    Review
  6. Pathogens (Basel, Switzerland) · 2021
    Article
  7. Review
  8. Article
  9. Sequence Comparison of Vaginolysin from DifferentPathogens (Basel, Switzerland) · 2021
    Article
  10. The Female Vaginal Microbiome in Health and Bacterial Vaginosis.Frontiers in cellular and infection microbiology · 2021
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Prevalence of vaginolysin, sialidase and phospholipase genes inMedical journal of the Islamic Republic of Iran · 2019
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Milda ZilnyteInstitute of Biotechnology, Vilnius University, Graičiūno 8, Vilnius LT-02241, Lithuania. milda.zilnyte@bti.vu.lt.
Česlovas VenclovasInstitute of Biotechnology, Vilnius University, Graičiūno 8, Vilnius LT-02241, Lithuania. ceslovas.venclovas@bti.vu.lt.
Aurelija ZvirblieneInstitute of Biotechnology, Vilnius University, Graičiūno 8, Vilnius LT-02241, Lithuania. aurelija.zvirbliene@bti.vu.lt.
Milda PleckaityteInstitute of Biotechnology, Vilnius University, Graičiūno 8, Vilnius LT-02241, Lithuania. milda.pleckaityte@bti.vu.lt.
Vilnius University · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gardnerella vaginalis produces cytolysin vaginolysin (VLY), which has been suggested to be a contributor to bacterial vaginosis pathogenesis. VLY along with intermedilysin (ILY) from Streptococcus intermedius have been attributed to a group of cholesterol-dependent cytolysins (CDCs) whose pore-forming activity depends on human CD59 (hCD59). Here, we show that different types of cells lacking hCD59 are susceptible to VLY-mediated lysis, albeit to different extents. We analyze the effects of both hCD59 and cholesterol on VLY cytolytic activity. We show that VLY binds to cholesterol-rich membranes of non-human cells, while VLY with an impaired cholesterol recognition site retains binding to the hCD59-containing cells. We further demonstrate that cholesterol binding by VLY is sufficient to trigger the formation of oligomeric complexes on cholesterol rich-liposomes lacking hCD59. Thus, VLY may induce cell lysis following two alternative pathways. One requires only cholesterol and does not depend on hCD59. The second pathway involves hCD59 contribution similarly to ILY. Apparently, under physiological conditions VLY acts in the most effective way by accepting the assistance of hCD59.

Indexed as

AdultAnimalsBacterial ProteinsBacterial ToxinsBacteriocinsCD59 AntigensCells, CulturedCHO CellsCholesterolCricetulusCytotoxinsErythrocytesHeLa CellsHumansMiceStreptolysinsBacterial ProteinsBacterial ToxinsBacteriocinsCD59 AntigensCD59 protein, humanCholesterolCytotoxinsintermedilysin protein, Streptococcus intermediusplY protein, Streptococcus pneumoniaeStreptolysinsvaginolysin, Gardnerella vaginalis

Identifiers

PMID25590277
PMCPMC4303817
OpenAlexW2057886539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.